Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by commissionson Mar 25, 2004 9:56am

247 Views

Post# 7263748

RE: ?????????

I would think so as they figured out yesterday that there is a short term obstacle present at .65, and will be there until he has liquidated his position.I did put a call into the company yesterday Asking them if it was possible to contact the trader and find out exactly how much is left and then asked them if they could persude one or some of the last PP institutions to mop it up. Its in everybodies best interests The Company The shareholders and The Institutions to move up share price to be able to get on the AMEX sooner than later.

Bullboard Posts

Dynamic Funds Launches new ETF series on the TSX